checkAd
    Startseite > Aktien > Akero Therapeutics > Nachrichten
    Akero Therapeutics Aktie
    21,600
     
    EUR
    +1,41 %
    +0,300 EUR
    Letzter Kurs 17:15:54 Tradegate
    21,480
     
    EUR
    470 STK
    Geldkurs 19:02:13
    21,620
     
    EUR
    470 STK
    Briefkurs 19:02:13
    ISIN: US00973Y1082 · WKN: A2PLNP · SYM: 0K4 · USA

    Neueste Nachrichten

    Akero Therapeutics Presents Poster and Late-breaking Oral Presentation on EFX at the EASL Congress 2024
    08.06.24 · globenewswire · Akero Therapeutics
    INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Akero Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
    07.06.24 · Business Wire (engl.) · Akero Therapeutics
    AKRO INVESTOR ALERT: Kirby McInerney LLP Notifies Akero Therapeutics, Inc. (AKRO) Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit
    03.06.24 · Business Wire (engl.) · Akero Therapeutics
    Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline for Securities Fraud Class Action Lawsuit Filed Against Akero Therapeutics, Inc. (AKRO)
    01.06.24 · Business Wire (engl.) · Akero Therapeutics
    Akero Therapeutics to Present at the Jefferies Global Healthcare Conference
    29.05.24 · globenewswire · Akero Therapeutics
    AKRO EQUITY ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Akero Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AKRO
    22.05.24 · Business Wire (engl.) · Akero Therapeutics
    Kirby McInerney LLP Reminds Akero Therapeutics, Inc. (AKRO) Investors of Class Action Filing and Encourages Investors to Contact the Firm
    14.05.24 · Business Wire (engl.) · Akero Therapeutics
    AKRO Stockholders with Large Losses Should Contact Robbins LLP for Information About the Class Action Against Akero Therapeutics, Inc.
    11.05.24 · Business Wire (engl.) · Akero Therapeutics
    Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Akero Therapeutics, Inc. (AKRO)
    10.05.24 · Business Wire (engl.) · Akero Therapeutics
    Akero Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
    10.05.24 · globenewswire · Akero Therapeutics
    Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Akero Therapeutics, Inc. (AKRO)
    09.05.24 · Business Wire (engl.) · Akero Therapeutics
    Akero Therapeutics to Present at the BofA Securities 2024 Health Care Conference
    08.05.24 · globenewswire · Akero Therapeutics